On November 24, 2015, Québec’s Minister of Health and Social Services, Gaétan Barrette introduced the following bill to Quebec’s National Assembly:
Bill 81: An Act to reduce the cost of certain medications covered by the basic prescription drug insurance plan by allowing calls for tender.
Bill 81 would amend the Act Respecting ... Read More
14
Dec2015
04
Dec2015
Ontario has released a summary, titled Minister’s Roundtable on Pan-Canadian Pharmacare, based on a roundtable discussion on pharmacare hosted by the Honourable Dr. Eric Hoskins, Ontario’s Minister of Health and Long-Term Care, on June 8, 2015. This summary, prepared by Health Quality Ontario, provides an overview of the discussion which ... Read More
25
Nov2015
PDCI has developed considerable expertise assisting manufacturers with product listing agreements(PLAs) through the pan-Canadian Pharmaceutical Alliance (pCPA), with individual provinces (including Quebec) and with private payers. With the formalization of the pCPA process and private payers moving aggressively into the PLA environment (see PDCIs white paper), PDCI is growing ... Read More
13
Nov2015
2015 FCA 249 Attorney General of Canada v Sandoz (A-302-14) & v ratiopharm (now Teva) (A-303-14).
The central issue in both appeals is whether the Federal Court judge properly held that Sandoz and ratiopharm (collectively the respondents) fell outside of the jurisdiction of the Board as they were not “patentees” within ... Read More
03
Nov2015
On Friday, October 30, 2015 PDCI presented a webinar entitled “Market Access Climate Change: the Evolving Impact of Product Listing Agreements”.
The purpose of this webinar was to:
Shed light on the recent developments at the pCPA; and
Enhance the understanding of the growing practice of PLA negotiations in the private payer ... Read More
26
Oct2015
As requested by stakeholders, the deadline for the following CADTH calls for stakeholder input has been extended to November 9, 2015 at 5:00 p.m. EST:
CDR Update – Issue 111
CADTH Consultation: Revisions to the Common Drug Review Procedure
Invites stakeholder comments and feedback on the following proposed revisions to the Procedure ... Read More
26
Oct2015
The Canadian Association for Healthcare Reimbursement (CAHR) is hosting a one-day event to discuss two key issues of relevance to the pharmaceutical and life sciences sectors following the October 2015 federal election. Maclean’s magazine’s and event moderator, Paul Wells, will be present to share his knowledge on innovation policy and ... Read More
20
Oct2015
Interested in learning more about new developments at the pan-Canadian Pharmaceutical Alliance (pCPA)?
Curious to know more about private payer Product Listing Agreements (PLAs) in Canada?
PDCI Market Access (PDCI) is hosting a free webinar on Friday, October 30, 2015 from 11:00 AM -12:00 PM EDT titled Market Access Climate Change: the ... Read More
16
Oct2015
INESSS is offering an opportunity for in-person meetings to manufacturers who have filed a submission by the deadline for drugs to be listed on the June 2016 “Liste des médicaments”. These meetings will be held between December 7 and December 18, 2015, inclusive.
Meetings will cover the following:
Discussion on clinical studies
Discussion ... Read More
16
Oct2015
In a recent update released on their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced two significant developments:
Québec is now participating in the pCPA; and
The Office of the pCPA (the Office) is now operational.
In Fall 2014, the Provincial/Territorial Health Ministers announced intentions for Québec’s participation in the Federation’s Health Care ... Read More